To the Editor: In February 2011, an 82-year-old woman was admitted into hospital for a chest infection. She had a history of viral cirrhosis, with a previous, minor episode of hepatic encephalopathy, a tendency to sleep -wake inversion, systemic hypertension, mood disorder, remote quadrantectomy for carcinoma breast, and accidental femur / fi bula fractures. She had been bedridden for periods of time. At home, she was on treatment with benzodiazepines, evening melatonin, pregabalin, olanzapine, ursodeoxycholic acid, and lactitol. On admission, she was started on ceft riaxone. As response was incomplete, on day 5 she was swapped to piperacillintazobactam, with almost immediate benefi t. While in hospital, a marked alteration of the sleep -wake cycle was confi rmed, with delayed sleep onset / off set times, numerous night awakenings, and excessive sleepiness in the morning. An electroencephalogram (EEG) recorded at 11:00 in the morning on day 2 showed a slowed background rhythm at 7 Hz, interspersed with sequences of slower activity at 2 -3 Hz, compatible with diffi culties maintaining wakefulness (slow / fast EEG activity ratio: 7.3). Sleep timing / quality monitoring was started on day 2, to include sleep diaries and repeat daytime assessments of subjective sleepiness (Karolinska Sleepiness Scale ( 1 )). On day 3, the patient was moved to a room with controlled lighting (Amadea wall-mounted lamp, with variable light intensity / spectrum; Derungs -Waldmann Illuminotecnica, San Giuliano Milanese, Italy). In order to advance her sleep -wake cycle, the lamp was set to automatically switch on at 06:30 and off at 22:30. In addition, light was more intense and blue enriched in the morning, whereas it became less intense and red enriched during the aft ernoon / evening hours. Sleepwake rhythms progressively improved, with reduced daytime sleepiness and fewer night awakenings ( Figure 1 ). An EEG recorded at 11:00 in the morning on day 9 confi rmed signifi cant improvement (slow / fast activity ratio: 3.1). Th e patient was discharged on day 15 on ursodeoxycholic acid, lactitol, and a reduced dose of olanzapine. Advice was provided on sleep and light hygiene at home. At 4 weeks, she remained well, with a residual tendency to delayed sleep habits but considerably improved morning vigilance and night sleep quality, not taking benzodiazepines or melatonin.
Night sleep disturbance and delayed sleep habits are common in patients with cirrhosis, regardless of their neuropsychia tric status ( 2, 3 ) . Excessive daytime sleepiness / napping are also common and generally associated with hepatic ence phalopathy ( 3 ) . Th e pathophysiology of these alterations is largely unknown. Delayed sleep habits have been ascribed to delayed melatonin rhythms, particularly in patients with decompensated cirrhosis ( 4 ) . Th e combination of delayed sleep habits, impaired sleep quality, and delayed melatonin rhythms is reminiscent of ' delayed sleep phase syndrome ' (DSPS), a circadian disorder characterized by considerable delays in sleep onset / wake-up times compared with the healthy population. Th e goal of DSPS treatment is to resynchronize the circadian clock with the 24-h light / dark cycle: structured sleep -wake schedules and avoidance of exposure to bright light in the evening are advised. In addition, exposure to bright light shortly aft er morning awakening has been shown to advance sleep timing ( 5 ) . Recent data suggest that bright blue enriched light may be particularly effi cacious in favoring wakefulness and phase advancing the melatonin rhythm ( 6 ) . In patients with cirrhosis, naturally occurring DSPS might be exacerbated by delayed hepatic melatonin metabolism and impaired sensi tivity of the retinal -hypothalamic tract to light cues ( 7 ), increasing its prevalence and / or modulating its features.
In this patient, the observed, extreme delay in sleep habits, bordering sleepwake inversion, was probably the result of cirrhosis plus a combination of other factors, including poor sleep / light hygiene, chronic use of benzodiazepines, and in appropriate use of melatonin. Advance of the sleep -wake rhythm and amelioration of sleep were obtained by removal of the precipitants, enforced wake-up schedules, and appropriately timed light adminis tration.
Th e treatment of sleep -wake disturbance in cirrhosis remains a challenge. Should the observed, benefi cial eff ect of light therapy be confi rmed by formal trials, a rational, non-pharmacological, and side-eff ect-free treatment might become available.
